net dbt
heat check gone
come next
set-up set near-term execut multipl expans
follow analyst day coupl solid quarter growth remain
optimist long-term trajectori busi comfort
compani execut view continu execut
next quarter enough drive slow steadi multipl expans
current price-to-earnings basi creat compel risk/reward
share also trade discount peer three separ sum-of-the-part analys
analysi insid note highlight upsid in-lin valuat reiter
buy rate increas price object
introduc long term ep growth guidanc analyst day june
compani expect low singl digit ep growth follow mid-singl digit
growth low doubl digit growth long-term growth algorithm
estim ebit/ep growth scenario
growth medium scenario growth high scenario
assumpt exclud benefit debt pay estim add
percentag point ep growth next year origin detail analysi
found
tweak estim higher po better visibl
head earn modestli adjust estim account
on-going busi stabil cost manag increas ep
ep back
expect solid perform increas price object
still base price-to-earnings also in-lin sotp
analysi think provid addit layer valuat support
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one largest healthcar compani
unit state provid retail mail
specialti pharmaci dispens servic
pharmaci benefit upon complet
acquisit aetna would becom one
vertic integr publicli trade
healthcar compani base
buy rate driven transform
vertic integr aetna stabl free cash
flow appeal valuat think
compani deal aetna provid ampl short-
term long-term synergi opportun
provid clear way extract valu
retail franchis stabl free cash flow
three busi allow
compani gener outsiz return
equiti next year
think
long-term ep guid achiev
introduc long term ep growth guidanc analyst day june
compani expect low singl digit ep growth follow mid-singl digit
growth low doubl digit growth beyond long-term growth
algorithm scenario analysi includ ebit/ep growth
scenario growth medium scenario growth
high scenario assumpt exclud benefit debt pay
estim add ep growth next year origin detail
analysi found
exhibit growth algorithm gener long-term ebit/ep growth mid-singl high-singl digit respect
share repurchas share outstand
profit per prescript like remain pressur intermedi term
revenu growth less relev profit per script ebit margin
shift e-commerce remain structur headwind
contribut ebit per sg leverag clinic shift like net neutral slight posit time
segment level analysi suggest revenu growth aetna reason
aetna stabl mlr posit modest improv sg leverag
weight averag growth base revenu segment
weight averag growth base ebit segment
base share repurchas target
everi share repurchas
valuat could expand certain scenario
return mid-singl digit ebit high-singl digit ep growth believ
share see signific multipl expans current level base
current trade less earn well peer averag
histori pay debt next year believ multipl could
expand least ep repres discount manag care peer
oper busi model fewer near-term uncertainti still meaning
increas current level furthermor assum grow ep mid-to-
high singl digit rang think share attract price today even
recent stock appreci
exhibit close ev/ebitda valuat gap
exhibit multipl discount widen three year
exhibit trade nearli turn discount market
exhibit trade discount peer price-to-earnings ratio basi ev/ebitda
exhibit valuat low end broader hc servic group ev/ebitda basi
exhibit price-to-earnings basi discount rel histori peer group
part yield potenti upsid
share under-valued across three differ sum-of-the-part analys
evalu first sotp analysi appli express script legaci multipl
exclud impact lost ep pharmaci servic busi
walgreen multipl retail/ltc busi anthem/ci multipl hc
benefit segment yield hypothet share price second sotp
appli ci valuat pharmaci servic hc benefit segment reflect
overlap busi walgreen multipl retail/ltc segment
conserv approach still yield upsid minimum
provid floor time hypothet share price third
sotp analysi believ repres upsid case current
valuat basi appli unh multipl pharmaci servic hc benefit
segment walgreen multipl retail/ltc segment yield hypothet
share price would note three scenario impli potenti
valu creation share today
exhibit worth current share price three differ sotp analys
million except per share data
factset bofa merril lynch global research estim
earn trajectori remaind year steadi
kick disappoint relat guidanc concern follow
initi guidanc came expect import least rememb
histori perform rel in-year guidanc
guidanc surpris guidanc provid novemb recent exampl
typic given year tend perform well rel plan
fact sinc one quarter meet/beat
exhibit extens histori come at/abov consensu ep
price object base ep estim multipl
five-year averag absolut basi lower end histor
rang also repres bigger discount vs last
retail pharmaci segment uncertainti around drug price
downsid risk po risk amazon anoth disrupt forc enter
suppli chain failur gener gener expect synergi aetna
transact regulatori issu relat post-clos activ grow
competit risk pharmaci benefit market includ competit price around
rebat on-going oper challeng long-term care pharmaci busi
headlin relat opioid litig slow prescription/insur trend upsid
risk po potenti prescript volum pickup faster stronger
expect synergi aetna improv front-end perform
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
